Experimental drug helps patients lose 85 pounds on average, study finds
Experimental drug retatrutide cut weight by nearly 30% in Phase 3 trials, outperforming approved therapies, Eli Lilly says.
Lilly weight loss drug results
- A Next-Generation Drug Causes Dramatic Weight Loss, Eli Lilly Says Time —
- New Eli Lilly weight loss drug has dramatic effects in clinical trial Washington Examiner —
- Eli Lilly says next-gen obesity drug helps patients lose 28% of body weight - Reuters Reuters —
- New weight-loss shot appears to outperform other obesity drugs on market The Guardian —
- Eli Lilly’s next-gen obesity drug beats Ozempic and Mounjaro, helps patients lose over 30% body weight in trial The Indian Express —